MedPath

Real Zero Fluoroscopy Catheter Ablation.

Conditions
Atrial Arrhythmia
Ventricular Arrythmia
Arrhythmias, Cardiac
Arrhythmia
Interventions
Procedure: Conventional ablation without 3D
Procedure: Zero fluoroscopy ablation
Procedure: Conventional ablation with 3D
Registration Number
NCT03458273
Lead Sponsor
Medical University of Lublin
Brief Summary

A Retrospective Propensity Matched Study comparing:

* real zero fluoroscopy catheter ablation

* conventional fluoroscopy catheter ablation without 3D system

* conventional fluoroscopy catheter ablation with 3D system

Detailed Description

Catheter ablation is a well-established treatment to treat patients with a wide scope of heart arrhythmias.

The study is an investigator-initiated, retrospective analysis of prospectively collected data. The study population consists of patients with right-sided arrhythmias who underwent zero-fluoroscopy catheter ablation between the years 2016 and 2018 in 3 centers and a propensity score matched patients group of patients who:

* underwent conventional fluoroscopy guided catheter ablation without 3D system (Ensite/Carto) support

* underwent conventional fluoroscopy guided catheter ablation with 3D system (Ensite/Carto) support

Covariates for matching will be:

* arrhythmia type

* age of a patient

* number of diagnostic catheters used during a procedure

* type of a diagnostic catheter used during a procedure\]

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • right atrial tachycardia
  • right atrial premature complexes
  • AVNRT
  • right atrial AVRT/WPW
  • right ventricle tachycardia / right ventricle premature complexes
Exclusion Criteria
  • left atrium arrhythmia
  • left ventricle arrhythmia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Conventional ablation without 3DConventional ablation without 3DPatients in whom Conventional fluoroscopy ablation was performed under fluoroscopic guidance only. Additional use of Ensite/Carto/Localisa for mapping was not allowed.
Zero fluoroZero fluoroscopy ablationPatients in whom Zero fluoroscopy ablation was performed under the guidance of Ensite for mapping and ablation and fluoroscopy will not be used during the procedure.
Conventional ablation with 3DConventional ablation with 3DPatients in whom Conventional fluoroscopy ablation was performed under fluoroscopic and Ensite/Carto guidance and ablation during the procedure. Use of fluoroscopy and additional Ensite/Carto for mapping and ablation was mandatory.
Primary Outcome Measures
NameTimeMethod
Procedural success rates3 months

arrhythmia recurrence within 3 months since the index procedure

Secondary Outcome Measures
NameTimeMethod
Recurrence rate6 months

arrhythmia recurrence within 6 months since the index procedure

Acute procedural success10-30 minutes

acute procedural success defined as arhhythia elimination

Fluoroscopy timeduring procedure

total fluoroscopy time during procedure

Total procedure timeduring procedure

total procedure time measured as needle to needle time

Acute Complications rateduring procedure

Procedural Complications procedure

The length of stay during the hospitalization1 month

Number of hospital days for ablation procedure from admission to discharge

All Complications rate6 months

Procedural Complications and Complications within 6 months since the index procedure

Trial Locations

Locations (3)

Wojewódzki Szpital Specjalistyczn

🇵🇱

Biała Podlaska, Poland

Medical University of Lublin

🇵🇱

Lublin, Poland

SP ZOZ Szpital Puławy

🇵🇱

Puławy, Poland

© Copyright 2025. All Rights Reserved by MedPath